These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37084865)

  • 21. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats.
    Al Zarzour RH; Ahmad M; Asmawi MZ; Kaur G; Saeed MAA; Al-Mansoub MA; Saghir SAM; Usman NS; Al-Dulaimi DW; Yam MF
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
    Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
    Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Xu QY; Li H; Cao HX; Pan Q; Fan JG
    Biomed Res Int; 2020; 2020():8869674. PubMed ID: 33294458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease.
    Stanković MN; Mladenović DR; Duričić I; Šobajić SS; Timić J; Jorgačević B; Aleksić V; Vučević DB; Ješić-Vukićević R; Radosavljević TS
    Arch Med Res; 2014 Feb; 45(2):116-24. PubMed ID: 24480733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice.
    Šmíd V; Dvořák K; Stehnová K; Strnad H; Rubert J; Stříteský J; Staňková B; Stránská M; Hajšlová J; Brůha R; Vítek L
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Effects of Monounsaturated Fatty Acids and Polyunsaturated Fatty Acids on Liver Lipid Disorders in Obese Mice.
    Liu W; Zhu M; Gong M; Zheng W; Zeng X; Zheng Q; Li X; Fu F; Chen Y; Cheng J; Rao Z; Lu Y; Chen Y
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
    Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD).
    Notarnicola M; Caruso MG; Tutino V; Bonfiglio C; Cozzolongo R; Giannuzzi V; De Nunzio V; De Leonardis G; Abbrescia DI; Franco I; Intini V; Mirizzi A; Osella AR
    Lipids Health Dis; 2017 Aug; 16(1):160. PubMed ID: 28830448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China.
    Zheng JS; Xu A; Huang T; Yu X; Li D
    Lipids; 2012 Jun; 47(6):549-56. PubMed ID: 22527845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.
    Feng R; Luo C; Li C; Du S; Okekunle AP; Li Y; Chen Y; Zi T; Niu Y
    Lipids Health Dis; 2017 Sep; 16(1):165. PubMed ID: 28870233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
    Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
    Luukkonen PK; Zhou Y; Sädevirta S; Leivonen M; Arola J; Orešič M; Hyötyläinen T; Yki-Järvinen H
    J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of N-stearoylethanolamine on plasma lipid composition in rats with experimental insulin resistance.
    Onopchenko OV; Kosiakova GV; Klimashevsky VM; Hula NM
    Ukr Biochem J; 2015; 87(1):46-54. PubMed ID: 26036130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors.
    Tiwari-Heckler S; Gan-Schreier H; Stremmel W; Chamulitrat W; Pathil A
    Nutrients; 2018 May; 10(5):. PubMed ID: 29883377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.